Status:
COMPLETED
Early Antiviral Therapy for Critically Ill HIV Infected Patients
Lead Sponsor:
Hospital Nossa Senhora da Conceicao
Conditions:
HIV Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of the study is to verify the effect of HAART in critically ill HIV infected patients. The current practice is to begin antiviral therapy after ICU discharge, when the condition of the patient...
Eligibility Criteria
Inclusion
- HIV infection
- CD4 cell count less than 350 cells/mm3 within 3 months prior to study entry OR CD4 cell count between 350 cells/mm3 and 500 cells/mm3 if age \> 55 years, coinfection with HBV or HCV, neoplasia, viral load \> 100,000 copies/ml or elevated cardiovascular risk OR AIDS-defining illness
Exclusion
- Regular use of HAART
- Pregnant
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2016
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT01455688
Start Date
January 1 2012
End Date
June 30 2016
Last Update
April 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Nossa Senhora da Conceicao
Porto Alegre, Rio Grande do Sul, Brazil